Home/Filings/4/0001104659-20-007113
4//SEC Filing

Mueller John Patrick 4

Accession 0001104659-20-007113

CIK 0001724344other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 4:04 PM ET

Size

14.9 KB

Accession

0001104659-20-007113

Insider Transaction Report

Form 4
Period: 2020-01-23
Mueller John Patrick
Chief Development Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-01-23+50,00050,000 total
    Exercise: $4.94Exp: 2030-01-22Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on January 1, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Entasis Therapeutics Holdings Inc.

CIK 0001724344

Entity typeother

Related Parties

1
  • filerCIK 0001751922

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:04 PM ET
Size
14.9 KB